Eli Lilly and Company · 3 days ago
Associate Director - External Innovation S&E Diabetes & Obesity
Indianapolis, IN
Full-time
Hybrid
Lead/Staff, Director/Executive
$146K/yr - $213K/yr
1+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on improving the lives of individuals living with Diabetes and Obesity. The Associate Director role involves developing and implementing the External Innovation strategy to secure pipeline impact in these areas, including identifying and evaluating new opportunities and managing partner interactions.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Identify and map new innovative opportunities with bold understanding of disease biology
Rigorously assess programs from biotech, small and large pharma companies for potential in-licensing/partnering opportunities that have been assigned for review by leadership or identified proactively
Manage all stages of partner interactions and evaluations, including initial contact, securing internal interest, meeting execution, coordinating internal debriefs, support CMR Search & Evaluation leadership as needed
Ensure prompt evaluation by functional experts (Biology, Chemistry, CMC, ADME, TOX, PK, legal etc.) for opportunity evaluation and pre-diligence and provide partners with essential feedback/guidance
Identify gaps and key issues and appropriate expertise to enable resolution
Collaborate with internal scientific teams to identify, design, and implement the scientific experiments necessary to validate external opportunities
Support consolidation of scientific feedback leading to internal recommendations and provision of partner responses
Maintain awareness of external competitive landscapes for key target areas and assets by actively monitoring all relevant external preclinical- and clinical-stage assets within therapeutic areas
Engage in scientific conferences as directed by CMR Search & Evaluation leadership to scout for new assets and technologies in line with R&D priorities
Provide regular updates at the EI deals review sessions
Qualification
Required
PhD in Life Sciences related field, with track record in pre-clinical research, deep understanding of R&D processes and new modalities in the Diabetes & Obesity area
Minimum of 1-5 years of experience in the pharmaceutical industry
Strong scientific pedigree as evidenced by publications and presentations
Minimum of 1-2 years of experience in external research collaborations and S&E
Preferred
Proven ability to work independently as well as in highly integrated cross functional teams
Strong interpersonal and communication skills and the ability to represent Lilly in a highly professional manner
Track record of participation to scientific conferences in the cardiometabolic /WHS area and partnering conferences
Demonstrated track record in managing complex partnerships
Benefits
Company bonus
401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
2026-01-11
2026-01-11
2026-01-11
Company data provided by crunchbase